AAAAAA
Results: 1-25/67
Authors:
Kakolyris, S
Giatromanolaki, A
Koukourakis, M
Powis, G
Souglakos, J
Sivridis, E
Georgoulias, V
Gatter, KC
Harris, AL
Citation: S. Kakolyris et al., Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer, CLIN CANC R, 7(10), 2001, pp. 3087-3091
Authors:
Papakostas, P
Kouroussis, C
Androulakis, N
Samelis, G
Aravantinos, G
Kalbakis, K
Sarra, E
Souglakos, J
Kakolyris, S
Georgoulias, V
Citation: P. Papakostas et al., First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study, EUR J CANC, 37(15), 2001, pp. 1833-1838
Authors:
Alexopoulos, A
Kouroussis, C
Malamos, N
Kakolyris, S
Kalbakis, K
Kosmas, C
Mavroudis, D
Agelaki, S
Vlachonicolis, J
Sarra, E
Rigatos, G
Georgoulias, V
Citation: A. Alexopoulos et al., Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: A multicenter phase II study, ANN ONCOL, 12(6), 2001, pp. 793-798
Authors:
Mavroudis, D
Papadakis, E
Veslemes, M
Tsiafaki, X
Stavrakakis, J
Kouroussis, C
Kakolyris, S
Bania, E
Jordanoglou, J
Agelidou, M
Vlachonicolis, J
Georgoulias, V
Citation: D. Mavroudis et al., A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer, ANN ONCOL, 12(4), 2001, pp. 463-470
Authors:
Kakolyris, S
Mavroudis, D
Tsavaris, N
Souglakos, J
Tsiafaki, P
Kalbakis, K
Agelaki, S
Androulakis, N
Georgoulias, V
Citation: S. Kakolyris et al., Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II study, ANN ONCOL, 12(2), 2001, pp. 193-197
Authors:
Stathopoulos, GP
Mavroudis, D
Tsavaris, N
Kouroussis, C
Aravantinos, G
Agelaki, S
Kakolyris, S
Rigatos, SK
Karabekios, S
Georgoulias, V
Citation: Gp. Stathopoulos et al., Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer, ANN ONCOL, 12(1), 2001, pp. 101-103
Authors:
Koukourakis, MI
Giatromanolaki, A
Kakolyris, S
Sivridis, E
Georgoulias, V
Funtzilas, G
Hickson, ID
Gatter, KC
Harris, AL
Citation: Mi. Koukourakis et al., Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/REF-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome, INT J RAD O, 50(1), 2001, pp. 27-36
Authors:
Kouroussis, C
Kakolyris, S
Mavroudis, D
Androulakis, N
Kalbakis, K
Agelaki, S
Sarra, E
Souglakos, J
Christodoulakis, M
Samonis, G
Georgoulias, V
Citation: C. Kouroussis et al., A dose-finding study of the weekly administration of paclitaxel in patients with advanced solid tumors, AM J CL ONC, 24(4), 2001, pp. 404-407
Authors:
Janinis, J
Papadakou, M
Panagos, G
Panousaki, A
Georgoulias, V
Hatzidaki, D
Lefantzis, D
Dokianakis, G
Citation: J. Janinis et al., Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracilin patients with locally advanced head and neck cancer, AM J CL ONC, 24(3), 2001, pp. 227-231
Authors:
Agelaki, S
Kakolyris, S
Palamidas, P
Kouroussis, C
Mavroudis, D
Kalbakis, K
Georgoulias, V
Raptis, A
Citation: S. Agelaki et al., A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer, LUNG CANC, 34(1), 2001, pp. 133-139
Authors:
Kakolyris, S
Papadakis, E
Tsiafaki, X
Kalofonos, C
Rapti, A
Toubis, M
Bania, E
Kouroussis, C
Chainis, K
Androulakis, N
Agelaki, S
Sarra, E
Vardakis, N
Georgoulias, V
Citation: S. Kakolyris et al., Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study, LUNG CANC, 32(2), 2001, pp. 179-187
Authors:
Georgoulias, V
Vlachonikolis, IG
Citation: V. Georgoulias et Ig. Vlachonikolis, Chemotherapy for non-small-cell lung cancer - Reply, LANCET, 358(9289), 2001, pp. 1271-1272
Authors:
Georgoulias, V
Papadakis, E
Alexopoulos, A
Tsiafaki, X
Rapti, A
Veslemes, M
Palamidas, P
Vlachonikolis, I
Citation: V. Georgoulias et al., Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial, LANCET, 357(9267), 2001, pp. 1478-1484
Authors:
Georgoulias, V
Scagliotti, G
Miller, V
Eckardt, J
Douillard, JY
Manegold, C
Citation: V. Georgoulias et al., Challenging the platinum combinations: Docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer, SEMIN ONCOL, 28(1), 2001, pp. 15-21
Authors:
Samonis, G
Anatoliotaki, M
Apostolakou, H
Souglakos, J
Georgoulias, V
Citation: G. Samonis et al., Fatal septicemia and meningitis due to Morganella morganii in a patient with Hodgkin's disease, SC J IN DIS, 33(7), 2001, pp. 553-555
Authors:
Kakolyris, S
Kouroussis, C
Souglakos, J
Mavroudis, D
Agelaki, S
Kalbakis, K
Androulakis, N
Vardakis, N
Vamvakas, L
Georgoulias, V
Citation: S. Kakolyris et al., A phase I clinical trial of topotecan given every 2 weeks in patients withrefractory solid tumors, ONCOL-BASEL, 61(4), 2001, pp. 265-270
Authors:
Kouroussis, C
Souglakos, J
Kakolyris, S
Mavroudis, D
Malamos, N
Kalbakis, K
Androulakis, N
Agelaki, A
Vardakis, N
Samonis, G
Georgoulias, V
Citation: C. Kouroussis et al., Oxaliplatin in combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced colorectal cancer: A phase II study, ONCOL-BASEL, 61(1), 2001, pp. 36-41
Authors:
Kakolyris, S
Souglakos, J
Kouroussis, C
Androulakis, N
Mavroudis, D
Kalbakis, K
Kotsakis, A
Vardakis, N
Koukourakis, M
Romanos, J
Georgoulias, V
Citation: S. Kakolyris et al., A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer, ONCOL-BASEL, 60(3), 2001, pp. 207-213
Authors:
Agelaki, S
Bania, H
Kouroussis, C
Blazoyiannakis, G
Sougalkos, J
Tsiafaki, X
Harpidou, A
Kalbakis, K
Rapti, A
Androulakis, N
Sarra, E
Georgoulias, V
Papadakis, E
Citation: S. Agelaki et al., Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: Two parallel multicenter phase II trials, ONCOL-BASEL, 60(3), 2001, pp. 235-241
Authors:
Kalbakis, K
Kouroussis, C
Kakolyris, S
Mavroudis, D
Souglakos, J
Agelaki, S
Vamvakas, L
Christodoulakis, M
Stylianou, K
Georgoulias, V
Citation: K. Kalbakis et al., Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuousinfusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes, BR J CANC, 85(6), 2001, pp. 798-802
Authors:
Koukourakis, MI
Giatromanolaki, A
Guddo, F
Kaklamanis, L
Vignola, M
Kakolyris, S
Turley, H
Georgoulias, V
Bonsignore, G
Gatter, KC
Harris, AL
Citation: Mi. Koukourakis et al., c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer, J IMMUNOTH, 23(1), 2000, pp. 104-114
Authors:
Chatzaki, E
Margioris, AN
Makrigiannakis, A
Castanas, E
Georgoulias, V
Gravanis, A
Citation: E. Chatzaki et al., Kappa opioids and TGF beta 1 interact in human endometrial cells, MOL HUM REP, 6(7), 2000, pp. 602-609
Authors:
Koukourakis, MI
Giatromanolaki, A
Kakolyris, S
Froudarakis, M
Georgoulias, V
Retalis, G
Bahlitzanakis, N
Citation: Mi. Koukourakis et al., Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer, MED ONCOL, 17(2), 2000, pp. 135-143
Authors:
Giatromanolaki, A
Koukourakis, MI
Stathopoulos, GP
Kapsoritakis, A
Paspatis, G
Kakolyris, S
Sivridis, E
Georgoulias, V
Harris, AL
Gatter, KC
Citation: A. Giatromanolaki et al., Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer, ONCOL RES, 12(1), 2000, pp. 33-41
Authors:
Giannakakis, T
Ziras, N
Kakolyris, S
Mavroudis, D
Androulakis, N
Agelaki, S
Parashos, M
Sarra, E
Dimou, T
Hatzidaki, D
Vlachonikolis, J
Georgoulias, V
Citation: T. Giannakakis et al., Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma: a multicentre phase I study, EUR J CANC, 36(6), 2000, pp. 742-747